Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib improves hair growth and quality of life in severe alopecia areata with longer use.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

A new topical treatment for hair loss is effective and safe with faster results.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

A 90-year-old man was diagnosed with heart failure due to wild-type transthyretin cardiac amyloidosis.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

BMS-470539 reduces skin fibrosis and inflammation.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Targeting TRP channels may help reduce excessive scarring.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Targeting Keratin 17 may help overcome cancer therapy resistance.